SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus Network

Aventus Network ($AVT) is trending, with community members pointing to its strong chart setup, real-world partnerships, and integration with Polkadot, which they believe positions the token for a potential breakout. Discussions highlight the token's low market cap and potential for significant upside, with traders closely monitoring volume as a key indicator for price movement.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around the self-proclaimed "culture coin," emphasizing its longevity and cultural significance. Many community members are sharing links to the project's website and DEX Screener, while also inviting others to join the Weedcoin community. The coin is being touted as "like Bitcoin but way higher."

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the crypto community debates its potential amid discussions around ETF possibilities and recent market dips. Some traders express frustration with XRP's performance compared to Bitcoin, while others remain bullish, citing long-term potential and upcoming catalysts. Community members are closely watching key price levels for potential breakouts or further declines.

HashPack is the leading retail wallet on Hedera Hashgraph with a fantastic user experience for defi, NFTs and dApps. The wallet is non-custodial, audited and features free email account creation as well as seed phrase based account creation. HashPack is integrated with every major dApp in the Hedera Hashgraph ecosystem and is deeply involved in the retail and developer communities.

HashPack

HashPack ($PACK) is trending as the community discusses its utility within the Hedera ecosystem, including staking, governance, and rewards. Recent updates, like the token buyback program and enhanced in-wallet functionality (Coinbase fiat onramp, improved DeFi swaps), are generating buzz. Speculation around a major app overhaul (dubbed "Project X") and potential cross-chain interoperability are also key talking points.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

Cel-Sci ($CVM) is trending due to the filing of a Breakthrough Medicine Designation application in Saudi Arabia for its Multikine immunotherapy, potentially leading to patient access and reimbursement within 60 days if approved. The community is focused on the implications of this filing with the SFDA and a potential partnership with Dallah Pharma for commercialization in the MENA region, aligning with Saudi's Vision 2030 goals in healthcare. Discussions also involve the possibility of accelerated FDA approval and the company's long-term potential in the biotech sector.

Hydrex is the MetaDEX & Liquidity Infrastructure purpose-built for Base. By combining automated strategies, liquid-backed tokenomics, and Base's powerful distribution channels, Hydrex removes the barriers to yield. It's designed as a coordination system where weekly community governance directs HYDX emissions & protocol revenue. Value flows to where liquidity and volume are most productive, based on protocol alignment.

Hydrex

Hydrex ($HYDX) is trending as a potential competitor to $AERO, with community members highlighting its recent launch on Base as a DUNA and its locked tokenomics. The project's low market cap and social media activity are fueling speculation about potential gains, with some anticipating a Coinbase listing.

CATULU | THE THREADED FAMILIAR  Catulu is like Tamagotchi for the Twitter age — except your pet lives on the timeline, and the more you play, the more everyone sees it.  Platform & Core Mechanics Platform: Twitter + Web3 (Solana) Core Loop: Tweeting = Feeding, Cleansing, Training Tokens: $CATULU (native currency of the ecosystem)   Level up your characters to unlock more avatar images , get into top ranks on leaderboard and earn LP rewards.

CATULU

CATULU is trending as community members highlight its availability on Phantom Wallet, making it easily accessible for trading. Some users are pointing to bullish chart patterns and anticipating further upward movement, while others suggest potential listings on larger exchanges. The overall sentiment is very positive, with many encouraging others to buy.

Aptos is a new, independent high-performance PoS Layer 1 project focused on delivering the safest and most scalable Layer 1 blockchain in the world. The Aptos blockchain leverages the Move programming language and the Move VM for application development, which are created and optimized for blockchain use cases.The team is comprised of the original creators, researchers, designers, and builders of Diem, the blockchain that was first built to serve this purpose. Aptos raised $200m from a16z, Multicoin, Binance and others. Aptos launched Devnet in mid March, incentivized testnet in late May and targets Q3 for mainnet launch.

Aptos

Aptos is trending as community members discuss its potential, with some calling it the "new Solana". The launch of the Trump stablecoin, USD1, on the Aptos blockchain is generating excitement, with investors speculating about increased adoption and potential price appreciation. Partnerships with World Liberty Finance and integrating Aave V3 have also sparked interest.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals is trending as the community discusses the potential of Neffy, its needle-free epinephrine spray, especially after recent global approvals and positive reception. Some are noting the company's strong financial backing and patent protection, while others discuss potential competition. Discussions also involve potential short squeeze setups and revenue projections.

Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It also designs surgical robotics. The company was founded by Adam Sachs, Sammy Khalifa, and Barry Greene on May 1, 2014 and is headquartered in Waltham, MA.

Vicarious Surgical Inc - Ordinary Shares - Class A

RBOT is trending as investors discuss the potential of its surgical robotics technology and recent Piper Sandler rating. Community members are weighing the company's cash runway against its long-term potential, with some anticipating a near-term capital raise or partnership. Despite concerns about dilution and clinical trial delays, some traders see a speculative buying opportunity due to the small float and backing from major investors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Nordson (NDSN) Up 3.5% Since Last Earnings Report?

Nordson (NDSN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Applied Industrial's Engineered Solutions Growth Picks Up: More Upside to Come?

AIT's Engineered Solutions gains from automation and acquisitions, offsetting fluid power softness.

Nordson's Expenses are on the Rise: Will It Affect Margins?

NDSN posts higher costs but sees margin gains as Advanced Technology Solutions and Atrion acquisition drive growth.

Implied Volatility Surging for Applied Industrial Technologies Stock Options

Investors need to pay close attention to AIT stock based on the movements in the options market lately.

Applied Industrial Technologies (AIT) Reliance on International Sales: What Investors Need to Know

Evaluate Applied Industrial Technologies' (AIT) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Applied Industrial Technologies (AIT) Reports Q4 Earnings: What Key Metrics Have to Say

The headline numbers for Applied Industrial Technologies (AIT) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Applied Industrial Q4 Earnings & Revenues Beat Estimates, Increase Y/Y

AIT posts Q4 EPS of $2.80, beating estimates, with revenues up 5.5% as acquisitions and Engineered Solutions growth drive gains.

Applied Industrial Technologies (AIT) Q4 Earnings and Revenues Beat Estimates

Applied Industrial Technologies (AIT) delivered earnings and revenue surprises of +7.69% and +3.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

AIT Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock?

Applied Industrial's Q4 results are likely to show revenue gains from automation and acquisitions, offset by weakness in Service Center operations.

Applied Industrial Technologies (AIT) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Get a deeper insight into the potential performance of Applied Industrial Technologies (AIT) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Applied Industrial Technologies, Inc. engages in the manufacture and distribution of industrial parts and products. It operates through the Service Center Based Distribution and Engineered Solutions segments. The Service Center Based Distribution segment is involved in local service centers and distribution centers with a focus on providing products and services addressing the maintenance and repair of motion control infrastructure and production equipment. The Engineered Solutions segment focuses on distributing, engineering, designing, integrating, and repairing hydraulic and pneumatic fluid power technologies, and engineered flow control products and services. The company was founded by Joseph Bruening in January 1923 and is headquartered in Cleveland, OH.

Applied Industrial Technologies Inc.

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$2.48	--	--	N/A
Q4 '25	$2.63	$2.84	8.12%	BEAT
Q3 '25	$2.41	$2.57	6.58%	BEAT
Q2 '25	--	$2.39	--	N/A
Q1 '25	$2.25	$2.36	4.69%	BEAT

AIT
Applied Industrial Technologies Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest AIT News

AIT Applied Industrial Technologies Inc.